GYS2

GYS2 is the hepatic glycogen synthase that catalyzes glycogen synthesis and serves as a transcriptionally controlled node coupling feeding state and the circadian clock to glycogen storage (PMID:20430893, PMID:24049741). Its transcription is directly driven by the core clock machinery: CLOCK binds two tandem E-box elements in the Gys2 promoter to impose circadian rhythmicity on hepatic glycogen synthesis (PMID:20430893), BMAL1 binds Gys2 promoter and intron regions with hepatocyte-specific Bmal1 loss abolishing this rhythmic expression (PMID:38183795), and PER2 associates with the Gys2 locus to drive the feeding-induced transcriptional response, such that Per2-deficient livers show reduced glycogen synthase during refeeding (PMID:24049741). Beyond classical GSK3-dependent acute control, insulin upregulates GYS2 transcription—shown in human endometrial epithelial cells where insulin both increases GYS2 mRNA and inactivates GSK3α/β to raise intracellular glycogen (PMID:29726999). GYS2 protein additionally functions in a tumor-suppressive p53 circuit in liver: it competitively binds MDM2 to block MDM2-mediated p53 ubiquitination and enhances p300-induced acetylation of p53 at K373/382, while p53 reciprocally represses GYS2 transcription via an HBx/HDAC1 complex, forming a negative feedback loop, and GYS2 overexpression suppresses hepatoma cell proliferation and migration with elevated p53 (PMID:30584071, PMID:38183795).

1. 2010 High

   Established that Gys2 transcription is under direct circadian clock control, explaining the daily rhythm of hepatic glycogen synthesis rather than treating GYS2 as a purely metabolically regulated enzyme.

   Evidence Reporter assays, in vivo liver ChIP for CLOCK at tandem E-boxes, and Clock mutant mice

   PMID:20430893

   Open questions at the time

   • Does not resolve how clock-driven transcription integrates with acute post-translational control of GYS2 activity
   • Did not test BMAL1 contribution directly
2. 2013 High

   Showed that the clock component PER2 is required for the feeding-induced transcriptional response of Gys2, linking nutrient timing to glycogen storage capacity.

   Evidence ChIP at Gys2 genomic regions, Per2(Brdm1) knockout mice, and protein/activity readouts across fasting-refeeding

   PMID:24049741

   Open questions at the time

   • Mechanism by which PER2 promotes rather than represses transcription at this locus not defined
   • Coordination with CLOCK/BMAL1 binding not directly mapped
3. 2013 Low

   Provided evolutionary evidence that GYS2 coding sequence was a target of adaptive selection in fruit bats, implicating it in dietary carbohydrate adaptation.

   Evidence Comparative coding-region sequencing across bat species with phylogenetic selection tests

   PMID:24258790

   Open questions at the time

   • Computational only; no functional validation of Q72H, K371Q, or E666D substitutions on enzyme activity
   • No mechanistic link to glycogen synthesis rate established
4. 2018 Medium

   Defined a non-enzymatic role for GYS2 protein in stabilizing p53, expanding GYS2 from a metabolic enzyme to a tumor-suppressive signaling component in hepatocellular carcinoma.

   Evidence Co-IP, ubiquitination and acetylation assays, and overexpression/knockdown in vitro and in vivo tumor models

   PMID:30584071

   Open questions at the time

   • Single-lab biochemistry without reciprocal independent confirmation of the MDM2-competition mechanism
   • Structural basis of GYS2-MDM2 binding unresolved
   • Whether catalytic activity is required for p53 stabilization untested
5. 2018 Medium

   Demonstrated that insulin upregulates GYS2 transcriptionally in addition to relieving GSK3 inhibition, identifying insulin (not progesterone) as the regulator of glycogen synthesis in endometrial epithelium.

   Evidence Primary human endometrial epithelial cells with insulin/MPA treatment, glycogen quantification, GSK3 phosphorylation, and GYS2 mRNA measurement

   PMID:29726999

   Open questions at the time

   • Transcription factor mediating insulin-induced GYS2 expression not identified
   • Generalizability beyond endometrial tissue not tested
6. 2023 Medium

   Confirmed BMAL1 as a direct positive regulator of rhythmic Gys2 expression and connected GYS2 to growth suppression, tying the circadian and p53 axes together.

   Evidence ChIP-seq, hepatocyte-specific Bmal1 knockout with 24-h qPCR time course, and proliferation/migration assays in HepG2 cells

   PMID:38183795

   Open questions at the time

   • Causal link between clock-driven GYS2 levels and p53-dependent tumor suppression not directly demonstrated
   • Whether reduced rhythmicity alters glycogen flux in vivo not quantified

• How GYS2's enzymatic glycogen-synthesis function mechanistically intersects with its p53-stabilizing role, and the transcription factors mediating insulin's effect, remain undefined.
• No structural model of GYS2-MDM2 interaction
• Insulin-responsive transcriptional pathway for GYS2 unidentified
• Integration of circadian, insulin, and p53 inputs on a single GYS2 pool not reconstituted